Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pathological Complete Response to Lenvatinib after Failure of Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.

Literature DB >> 35634428

Pathological Complete Response to Lenvatinib after Failure of Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.

Yusuke Johira¹, Tomokazu Kawaoka¹, Masanari Kosaka¹, Yuki Shirane¹, Ryoichi Miura¹, Serami Murakami¹, Shigeki Yano¹, Kei Amioka¹, Kensuke Naruto¹, Yuwa Ando¹, Yumi Kosaka¹, Kenichiro Kodama¹, Shinsuke Uchikawa¹, Hatsue Fujino¹, Atsushi Ono¹, Takashi Nakahara¹, Eisuke Murakami¹, Wataru Okamoto¹, Masami Yamauchi¹, Michio Imamura¹, Kazuhiro Sentani², Naohide Oue², Koji Arihiro³, Shintaro Kuroda⁴, Tsuyoshi Kobayashi⁴, Hideki Ohdan⁴, Kazuaki Chayama¹, Hiroshi Aikata¹.

Abstract

Entities: Chemical

Year: 2021 PMID： 35634428 PMCID： PMC9109072 DOI： 10.1159/000520898

Source DB: PubMed Journal: Liver Cancer ISSN： 1664-5553 Impact factor: 12.430

Keyword Cloud
References

× No keyword cloud information.

5 in total

1. OATP1B3 expression is strongly associated with Wnt/β-catenin signalling and represents the transporter of gadoxetic acid in hepatocellular carcinoma.

Authors: Akihisa Ueno; Yohei Masugi; Ken Yamazaki; Mina Komuta; Kathryn Effendi; Yutaka Tanami; Hanako Tsujikawa; Akihiro Tanimoto; Shigeo Okuda; Osamu Itano; Yuko Kitagawa; Sachio Kuribayashi; Michiie Sakamoto
Journal: J Hepatol Date: 2014-06-16 Impact factor: 25.083

2. Pretreatment Heterogeneous Enhancement Pattern of Hepatocellular Carcinoma May Be a Useful New Predictor of Early Response to Lenvatinib and Overall Prognosis.

Authors: Yusuke Kawamura; Masahiro Kobayashi; Junichi Shindoh; Yuta Kobayashi; Kayoko Kasuya; Tomoya Sano; Shunichiro Fujiyama; Tetsuya Hosaka; Satoshi Saitoh; Hitomi Sezaki; Norio Akuta; Fumitaka Suzuki; Yoshiyuki Suzuki; Kenji Ikeda; Yasuji Arase; Masaji Hashimoto; Hiromitsu Kumada
Journal: Liver Cancer Date: 2020-02-04 Impact factor: 11.740

3. Characteristics and Lenvatinib Treatment Response of Unresectable Hepatocellular Carcinoma with Iso-High Intensity in the Hepatobiliary Phase of EOB-MRI.

Authors: Akinori Kubo; Goki Suda; Megumi Kimura; Osamu Maehara; Yoshimasa Tokuchi; Takashi Kitagataya; Masatsugu Ohara; Ren Yamada; Taku Shigesawa; Kazuharu Suzuki; Naoki Kawagishi; Masato Nakai; Takuya Sho; Mitsuteru Natsuizaka; Kenichi Morikawa; Koji Ogawa; Shunsuke Ohnishi; Naoya Sakamoto
Journal: Cancers (Basel) Date: 2021-07-20 Impact factor: 6.639

4. Tumor Fibroblast Growth Factor Receptor 4 Level Predicts the Efficacy of Lenvatinib in Patients With Advanced Hepatocellular Carcinoma.

Authors: Masami Yamauchi; Atsushi Ono; Akira Ishikawa; Kenichiro Kodama; Shinsuke Uchikawa; Haruna Hatooka; Peiyi Zhang; Yuji Teraoka; Kei Morio; Hatsue Fujino; Takashi Nakahara; Eisuke Murakami; Daiki Miki; Tomokazu Kawaoka; Masataka Tsuge; Akira Hiramatsu; Michio Imamura; Clair Nelson Hayes; Masashi Fujita; Hidewaki Nakagawa; Wataru Yasui; Hiroshi Aikata; Kazuaki Chayama
Journal: Clin Transl Gastroenterol Date: 2020-05 Impact factor: 4.396

5 in total